Skip to main content
Equibles

683 Capital Management, LLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1404574 NEW YORK, NY
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,773,000
+$4,743,500 QoQ
Shares Held
650,000
+97.0% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#3
of 95 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

683 Capital Management, LLC holds $349,034,024 across 34 Biotechnology names. RNAC ranks #16 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ANAB
Anaptysbio, Inc
 660,000 $44,550,000
2 PTGX
Protagonist Therapeutics, Inc
 290,000 $35,548,200
3 MGTX
MeiraGTx Holdings plc
 2,300,000 $31,073,000
4 WVE
Wave Life Sciences, Inc.
 4,950,000 $28,759,500
5 QURE
uniQure N.V.
 575,000 $26,484,500
6 TGTX
Tg Therapeutics, Inc.
 389,081 $21,376,110
7 PHAT
Phathom Pharmaceuticals, Inc.
 1,850,000 $20,072,500
8 TRAX
First Tracks Biotherapeutics, Inc.
 750,000 $15,090,000

All Filings in RNAC

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,773,000 650,000
2026-03-31 $2,029,500 330,000
2025-12-31 $2,018,800 280,000
2025-09-30 $2,350,600 230,000
2025-06-30 $2,275,410 219,000
2025-03-31 $1,977,000 150,000
2024-12-31 $2,238,750 125,000
2024-09-30 $1,215,947 75,431
2020-12-31 $2,165,295 714,619
2020-09-30 $1,772,255 714,619
2020-06-30 $2,029,517 714,619
2020-03-31 $1,722,231 714,619